BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, Wada H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery 2007;141:196-202. [PMID: 17263976 DOI: 10.1016/j.surg.2006.06.033] [Cited by in Crossref: 151] [Cited by in F6Publishing: 140] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Li Q, Zhai Y, Luo W, Zhu Z, Zhang X, Xie S, Hong C, Wang Y, Su Y, Zhao J, Wang C. Synthesis and biological properties of polyamine modified flavonoids as hepatocellular carcinoma inhibitors. European Journal of Medicinal Chemistry 2016;121:110-9. [DOI: 10.1016/j.ejmech.2016.04.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
2 Furumoto K, Miura K, Nagashima D, Kojima H, Mori T, Ito D, Kajimura K, Kogire M. Solitary metastasis to the intercostal muscle from hepatocellular carcinoma: A case report. Int J Surg Case Rep. 2012;3:322-326. [PMID: 22554941 DOI: 10.1016/j.ijscr.2012.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
3 Nishie A, Asayama Y, Ishigami K, Kakihara D, Nakayama T, Ushijima Y, Takayama Y, Shirabe K, Fujita N, Kubo Y, Hirakawa M, Honda H. Clinicopathological significance of the peritumoral decreased uptake area of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in hepatocellular carcinoma. J Gastroenterol Hepatol 2014;29:561-7. [PMID: 24219648 DOI: 10.1111/jgh.12423] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
4 Tang J, Cui J, Chen R, Guo K, Kang X, Li Y, Gao D, Sun L, Xu C, Chen J, Tang Z, Liu Y. A three-dimensional cell biology model of human hepatocellular carcinoma in vitro. Tumour Biol 2011;32:469-79. [PMID: 21140254 DOI: 10.1007/s13277-010-0140-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
5 Li T, Wang SK, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC. Liver Int 2016;36:284-92. [PMID: 26104132 DOI: 10.1111/liv.12898] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
6 Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM, Zheng SS. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29:1810-1816. [PMID: 21678027 DOI: 10.1007/s12032-011-0004-z] [Cited by in Crossref: 360] [Cited by in F6Publishing: 388] [Article Influence: 32.7] [Reference Citation Analysis]
7 Lu S, Zhou W, Wei H, He L, Li L. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin. Dig Dis Sci 2015;60:3681-90. [PMID: 26280083 DOI: 10.1007/s10620-015-3824-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
8 Hwang SH, Lee JW, Cho HJ, Kim KS, Choi GH, Yun M. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Very Early and Early Hepatocellular Carcinoma. Clin Nucl Med. 2017;42:34-39. [PMID: 27775949 DOI: 10.1097/rlu.0000000000001449] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
9 Jun L, Zhenlin Y, Renyan G, Yizhou W, Xuying W, Feng X, Yong X, Kui W, Jian L, Dong W, Hongyang W, Lehua S, Mengchao W, Feng S. Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy. Oncologist 2012;17:963-9. [PMID: 22653882 DOI: 10.1634/theoncologist.2011-0447] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
10 Berger Y, Spivack JH, Heskel M, Aycart SN, Labow DM, Sarpel U. Extrahepatic metastasectomy for hepatocellular carcinoma: Predictors of long-term survival. J Surg Oncol. 2016;114:469-474. [PMID: 27334650 DOI: 10.1002/jso.24340] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
11 Cillo U, Giuliani T, Polacco M, Herrero Manley LM, Crivellari G, Vitale A. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World J Gastroenterol 2016; 22(1): 232-252 [PMID: 26755873 DOI: 10.3748/wjg.v22.i1.232] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
12 Liu Z, Chen M, Xie LK, Liu T, Zou ZW, Li Y, Chen P, Peng X, Ma C, Zhang WJ, Li PD. CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling. Aging (Albany NY) 2018;10:2570-84. [PMID: 30312171 DOI: 10.18632/aging.101571] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
13 Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Cancer. 2013;119:126-135. [PMID: 22736338 DOI: 10.1002/cncr.27697] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
14 Ding X, Wang K, Wang H, Zhang G, Liu Y, Yang Q, Chen W, Hu S. High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection. J Gastrointest Surg. 2012;16:828-836. [PMID: 22072303 DOI: 10.1007/s11605-011-1775-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
15 Senthilnathan S, Memon K, Lewandowski RJ, Kulik L, Mulcahy MF, Riaz A, Miller FH, Yaghmai V, Nikolaidis P, Wang E. Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients. Hepatology. 2012;55:1432-1442. [PMID: 22109811 DOI: 10.1002/hep.24812] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
16 Liang Y, Li E, Min J, Gong C, Gao J, Ai J, Liao W, Wu L. miR‑29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3. Oncol Rep 2018;40:3261-72. [PMID: 30272306 DOI: 10.3892/or.2018.6745] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
17 Byeon J, Cho EH, Kim SB, Choi DW. Extrahepatic recurrence of hepatocellular carcinoma after curative hepatic resection. Korean J Hepatobiliary Pancreat Surg 2012;16:93-7. [PMID: 26388915 DOI: 10.14701/kjhbps.2012.16.3.93] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
18 Chua TC, Morris DL. Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma. Surg Oncol. 2012;21:95-101. [PMID: 21397495 DOI: 10.1016/j.suronc.2011.01.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
19 Tanaka K, Matsuyama R, Takeda K, Matsuo K, Nagano Y, Endo I. Aggressive liver resection including major-vessel resection for colorectal liver metastases. World J Hepatol 2009; 1(1): 79-89 [PMID: 21160969 DOI: 10.4254/wjh.v1.i1.79] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
20 Liao HY, Liao B, Zhang HH. CISD2 plays a role in age-related diseases and cancer. Biomed Pharmacother 2021;138:111472. [PMID: 33752060 DOI: 10.1016/j.biopha.2021.111472] [Reference Citation Analysis]
21 Nishie A, Yoshimitsu K, Irie H, Tajima T, Hirakawa M, Ishigami K, Ushijima Y, Okamoto D, Nishihara Y, Taketomi A, Honda H. Radiological detectability of minute hepatic venous invasion in hepatocellular carcinoma. European Journal of Radiology 2009;70:517-24. [DOI: 10.1016/j.ejrad.2008.02.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
22 Cho CS. Prognostication systems as applied to primary and metastatic hepatic malignancies. Surg Oncol Clin N Am 2015;24:41-56. [PMID: 25444468 DOI: 10.1016/j.soc.2014.09.010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Yoneda N, Sato Y, Kitao A, Ikeda H, Sawada-Kitamura S, Miyakoshi M, Harada K, Sasaki M, Matsui O, Nakanuma Y. Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma. Lab Invest. 2011;91:262-272. [PMID: 20856226 DOI: 10.1038/labinvest.2010.161] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
24 Yang X, Chen SL, Lin CS, Liu LL, Wang CH, Yun JP. Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma. Pathol Res Pract 2020;216:153153. [PMID: 32891822 DOI: 10.1016/j.prp.2020.153153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Imura S, Teraoku H, Yoshikawa M, Ishikawa D, Yamada S, Saito Y, Iwahashi S, Ikemoto T, Morine Y, Shimada M. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria. Int J Clin Oncol 2018;23:98-103. [PMID: 28875240 DOI: 10.1007/s10147-017-1189-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
26 Tokuhisa Y, Iizuka N, Sakaida I, Moribe T, Fujita N, Miura T, Tamatsukuri S, Ishitsuka H, Uchida K, Terai S, Sakamoto K, Tamesa T, Oka M. Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma. Br J Cancer 2007;97:1399-403. [PMID: 17940509 DOI: 10.1038/sj.bjc.6604034] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
27 Flecken T, Spangenberg HC, Thimme R. Immunobiology of hepatocellular carcinoma. Langenbecks Arch Surg. 2012;397:673-680. [PMID: 21479622 DOI: 10.1007/s00423-011-0783-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
28 Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B, Hood L, Wang H, Yang S, Gu J. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol. 2009;50:948-957. [PMID: 19303159 DOI: 10.1016/j.jhep.2008.11.020] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 7.0] [Reference Citation Analysis]
29 Yang GH, Fan J, Xu Y, Qiu SJ, Yang XR, Shi GM, Wu B, Dai Z, Liu YK, Tang ZY. Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. Oncologist. 2008;13:1155-1165. [PMID: 18997126 DOI: 10.1634/theoncologist.2008-0081] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
30 Taketomi A, Toshima T, Kitagawa D, Motomura T, Takeishi K, Mano Y, Kayashima H, Sugimachi K, Aishima S, Yamashita Y, Ikegami T, Gion T, Uchiyama H, Soejima Y, Maeda T, Shirabe K, Maehara Y. Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol. 2010;17:2740-2746. [PMID: 20411432 DOI: 10.1245/s10434-010-1076-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
31 Takahashi Y, Ikeda N, Nakajima J, Sawabata N, Chida M, Horio H, Okumura S, Kawamura M;  Metastatic Lung Tumor Study Group of Japan. Prognostic Analysis of Surgical Resection for Pulmonary Metastasis from Hepatocellular Carcinoma. World J Surg. 2016;40:2178-2185. [PMID: 27255943 DOI: 10.1007/s00268-016-3580-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
32 Yu S, Estess A, Harris W, Dillon J. A Rare Occurrence of Hepatocellular Carcinoma Metastasis to the Mandible: Report of a Case and Review of the Literature. Journal of Oral and Maxillofacial Surgery 2012;70:1219-23. [DOI: 10.1016/j.joms.2012.01.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
33 Zhou S, Zhou Z, Hu Z, Song C, Luo Y, Luo C, Xin H, Yang X, Shi Y, Wang Z, Huang X, Cao Y, Fan J, Zhou J. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence. Journal of Hepatology 2019;71:1152-63. [DOI: 10.1016/j.jhep.2019.07.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
34 Gan Q, Shao J, Cao Y, Lei J, Xie P, Ge J, Hu G. USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma. Life Sci 2020;261:118316. [PMID: 32835698 DOI: 10.1016/j.lfs.2020.118316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Imura S, Yamada S, Saito Y, Ikemoto T, Morine Y, Shimada M. Utility of cone unit liver resection for small hepatocellular carcinoma: a propensity score matched analysis. HPB 2021;23:739-45. [DOI: 10.1016/j.hpb.2020.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Chen Y, Zeng J, Guo P, Zeng J, Liu J. Prognostic Significance of Platelet-to-Lymphocyte Ratio (PLR) in Extrahepatic Metastasis of Hepatocellular Carcinoma After Curative Resection. Cancer Manag Res 2021;13:1395-405. [PMID: 33603483 DOI: 10.2147/CMAR.S290738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zhao J, Dong QZ, Zhong F, Cai LL, Qin ZY, Liu Y, Lin CZ, Qin LX, He FC. NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway. Oncotarget 2017;8:12174-85. [PMID: 28077802 DOI: 10.18632/oncotarget.14556] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
38 Zubair T, Yen T, Gao G. Solitary Extrahepatic Intramuscular Metastasis from Cryptogenic Hepatocellular Carcinoma. ACG Case Rep J 2018;5:e64. [PMID: 30238018 DOI: 10.14309/crj.2018.64] [Reference Citation Analysis]
39 Sun W, Dong WW, Mao LL, Li WM, Cui JT, Xing R, Lu YY. Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma. World J Gastroenterol 2013; 19(19): 2913-2920 [PMID: 23704824 DOI: 10.3748/wjg.v19.i19.2913] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
40 He Q, Tao L, Xu H, Xie X, Cheng S. Circ_0072995 Promotes Proliferation and Invasion via Regulating miR-1253/EIF4A3 Signaling in HCC. Cancer Manag Res 2021;13:5981-7. [PMID: 34377018 DOI: 10.2147/CMAR.S316559] [Reference Citation Analysis]
41 Kawasaki Y, Yang SJ, Choi GH, Han DH, Lee JH, Iino S, Sakoda M, Ueno S, Natsugoe S, Choi JS. New scoring system for resectable hepatocellular carcinoma with a maximum tumor size of ≤5 cm based on preoperative tumor factors. HPB (Oxford) 2019;21:1393-9. [PMID: 30922846 DOI: 10.1016/j.hpb.2019.02.018] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Lee YJ, Kim JH, Song H, Park J, Na HK, Kim PH, Fan Y. Hepatocellular Carcinoma Complicated by Gastroduodenal Obstruction: Palliative Treatment with Metallic Stent Placement. Cardiovasc Intervent Radiol 2012;35:1129-35. [DOI: 10.1007/s00270-011-0262-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
43 Nishie A, Tajima T, Asayama Y, Ishigami K, Hirakawa M, Ushijima Y, Kakihara D, Okamoto D, Fujita N, Taketomi A, Yoshimitsu K, Honda H. Radiological assessment of hepatic vein invasion by hepatocellular carcinoma using combined computed tomography hepatic arteriography and computed tomography arterial portography. Jpn J Radiol 2010;28:414-22. [PMID: 20661691 DOI: 10.1007/s11604-010-0442-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Duan J, Qian Y, Fu X, Chen M, Liu K, Liu H, Yang J, Liu C, Chang Y. TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma. Aging (Albany NY) 2021;13:5585-606. [PMID: 33591950 DOI: 10.18632/aging.202487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zhang Z, Yan Z, Yuan Z, Sun Y, He H, Mai C. SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma. Tumour Biol 2015;36:1503-9. [PMID: 25537088 DOI: 10.1007/s13277-014-2665-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
46 Maeda Y, Yoshimura K, Matsui H, Shindo Y, Tamesa T, Tokumitsu Y, Hashimoto N, Tokuhisa Y, Sakamoto K, Sakai K. Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial. Cancer Immunol Immunother. 2015;64:1047-1056. [PMID: 25982372 DOI: 10.1007/s00262-015-1709-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
47 Chen L, Li M, Li Q, Wang CJ, Xie SQ. DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway. Mol Cancer. 2013;12:157. [PMID: 24325363 DOI: 10.1186/1476-4598-12-157] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 8.2] [Reference Citation Analysis]
48 Wang Y, Zhang B, Huang Y, Yao W, Tao F, Chen Y. Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway. Molecules 2021;26:3915. [PMID: 34206871 DOI: 10.3390/molecules26133915] [Reference Citation Analysis]
49 Chen S, Gao Y, Li Z, Jia J, Fang M, Wang M, Feng H, Chen Q, Guan W, Wang Z, Gao C. A Nomogram Predicting Extrahepatic Metastases for Patients with Adjuvant Transarterial Chemoembolization after Hepatectomy. J Cancer 2018;9:4223-33. [PMID: 30519323 DOI: 10.7150/jca.25886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology. 2012;56:2242-2254. [PMID: 22711685 DOI: 10.1002/hep.25907] [Cited by in Crossref: 189] [Cited by in F6Publishing: 174] [Article Influence: 21.0] [Reference Citation Analysis]
51 Wu J, Shen SL, Chen B, Nie J, Peng BG. Numb promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma. PLoS One. 2014;9:e95849. [PMID: 24770339 DOI: 10.1371/journal.pone.0095849] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
52 Tanaka K, Ichikawa Y, Endo I. Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review. Int J Clin Oncol. 2011;16:452-463. [PMID: 21786210 DOI: 10.1007/s10147-011-0291-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
53 Zhang H, Liu S, Chen L, Sheng Y, Luo W, Zhao G. MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma. Bioengineered 2021;12:2263-73. [PMID: 34115554 DOI: 10.1080/21655979.2021.1932210] [Reference Citation Analysis]
54 Yoon JH, Lee WJ, Kim SM, Kim KT, Cho SB, Kim HJ, Ko YS, Kook HY, Jun CH, Choi SK, Kim BS, Cho SY, You HS, Lee Y, Son S. Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Sci Rep 2021;11:12984. [PMID: 34155324 DOI: 10.1038/s41598-021-92503-6] [Reference Citation Analysis]
55 Aino H, Sumie S, Niizeki T, Kuromatsu R, Tajiri N, Nakano M, Satani M, Okamura S, Shimose S, Miyahara K, Torimura T. The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis. Mol Clin Oncol 2016;5:83-8. [PMID: 27330772 DOI: 10.3892/mco.2016.879] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
56 Orita K, Sakamoto A, Okamoto T, Matsuda S. Solitary Muscle Metastasis of Hepatocellular Carcinoma to the Biceps Femoris Muscle with Only Elevated Serum PIVKA-II: A Case Report. Am J Case Rep. 2019;20:306-309. [PMID: 30846677 DOI: 10.12659/ajcr.913730] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
57 Kim JM, Lee SH, Shin WY, Lee KY, Kim JM, Ahn SI. Intrahepatic recurrence of single nodular hepatocellular carcinoma after surgical resection: an analysis by segmental distribution. ANZ J Surg 2018;88:E840-4. [PMID: 30225975 DOI: 10.1111/ans.14824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Wang J, Li J, Wang X, Zheng C, Ma W. Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis. Biochem Biophys Res Commun. 2013;439:47-53. [PMID: 23962428 DOI: 10.1016/j.bbrc.2013.08.032] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
59 Mashiko T, Masuoka Y, Nakano A, Tsuruya K, Hirose S, Hirabayashi K, Kagawa T, Nakagohri T. Intussusception due to hematogenous metastasis of hepatocellular carcinoma to the small intestine: A case report. World J Gastroenterol 2020; 26(42): 6698-6705 [PMID: 33268957 DOI: 10.3748/wjg.v26.i42.6698] [Reference Citation Analysis]
60 Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Sakata K, Matsugaki S, Kajiwara M, Fukuizumi K, Tajiri N, Matsukuma N. Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma. Oncology. 2013;84:108-114. [PMID: 23147476 DOI: 10.1159/000342650] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
61 Kim K, Kim TH, Kim TH, Seong J. Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis. J Hepatocell Carcinoma 2021;8:35-44. [PMID: 33604314 DOI: 10.2147/JHC.S290197] [Reference Citation Analysis]
62 Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, Komeda K, Inoue Y, Uchiyama K. Surgical treatment of extrahepatic recurrence of hepatocellular carcinoma. Langenbecks Arch Surg. 2014;399:1057-1064. [PMID: 25030500 DOI: 10.1007/s00423-014-1230-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
63 Li J, Liu Y, Yan Z, Wan X, Xia Y, Wang K, Liu J, Lau WY, Wu M, Shen F. A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy. Br J Cancer 2014;110:1110-7. [PMID: 24481404 DOI: 10.1038/bjc.2014.19] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
64 Li T, Qin LX, Gong X, Zhou J, Sun HC, Wang L, Qiu SJ, Ye QH, Fan J. Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma. Surgery 2014;156:651-60. [PMID: 24998159 DOI: 10.1016/j.surg.2014.04.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
65 Nagano H, Obi S, Hatano E, Kaneko S, Kanai F, Omata M, Tsuji A, Itamoto T, Yamamoto K, Tanaka M, Kubo S, Hirata K, Nakamura H, Tomimaru Y, Yamanaka T, Kojima S, Monden M. Multicenter, randomized, controlled trial of S-1 monotherapy versus S-1 and interferon-α combination therapy for hepatocellular carcinoma with extrahepatic metastases: S-1 alone vs. S-1/IFN-α in HCC. Hepatol Res 2018;48:717-26. [DOI: 10.1111/hepr.13067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Gao J, Li E, Liu W, Yang Q, Xie C, Ai J, Zhou F, Liao W, Wu L. Circular RNA MYLK Promotes Hepatocellular Carcinoma Progression Through the miR29a/KMT5C Signaling Pathway. Onco Targets Ther 2020;13:8615-27. [PMID: 32904604 DOI: 10.2147/OTT.S258715] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
67 He ZL, Zheng H, Lin H, Miao XY, Zhong DW. Overexpression of polo-like kinase1 predicts a poor prognosis in hepatocellular carcinoma patients. World J Gastroenterol 2009; 15(33): 4177-4182 [PMID: 19725153 DOI: 10.3748/wjg.15.4177] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
68 Wang F, Qiao Y, Yu J, Ren X, Wang J, Ding Y, Zhang X, Ma W, Ding Y, Liang L. FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma. PLoS One 2013;8:e65495. [PMID: 23826080 DOI: 10.1371/journal.pone.0065495] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
69 Yu X, Zheng Y, Zhu X, Gao X, Wang C, Sheng Y, Cheng W, Qin L, Ren N, Jia H, Dong Q. Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway. Oncol Lett 2018;16:5299-308. [PMID: 30250599 DOI: 10.3892/ol.2018.9281] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
70 Liu K, Duan J, Liu H, Yang X, Yang J, Wu M, Chang Y. Precancer antiviral treatment reduces microvascular invasion of early-stage Hepatitis B-related hepatocellular carcinoma. Sci Rep 2019;9:2220. [PMID: 30778112 DOI: 10.1038/s41598-019-39440-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
71 Yoshioka S, Takemasa I, Nagano H, Kittaka N, Noda T, Wada H, Kobayashi S, Marubashi S, Takeda Y, Umeshita K. Molecular prediction of early recurrence after resection of hepatocellular carcinoma. Eur J Cancer. 2009;45:881-889. [PMID: 19167881 DOI: 10.1016/j.ejca.2008.12.019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
72 Nishie A, Yoshimitsu K, Asayama Y, Irie H, Tajima T, Hirakawa M, Ishigami K, Nakayama T, Kakihara D, Nishihara Y, Taketomi A, Honda H. Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR Am J Roentgenol 2008;190:81-7. [PMID: 18094297 DOI: 10.2214/AJR.07.2810] [Cited by in Crossref: 60] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
73 Zheng N, Zhang S, Wu W, Zhang N, Wang J. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma. Pharmacol Res 2021;166:105507. [PMID: 33610718 DOI: 10.1016/j.phrs.2021.105507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
74 Poddar N, Ramlal R, Ravulapati S, Devlin SM, Gadani S, Vidal CI, Cao D, Befeler AS, Lai J. Extrahepatic metastasis of hepatocellular carcinoma arising from a hepatic adenoma without concurrent intrahepatic recurrence. Curr Oncol 2017;24:e333-6. [PMID: 28874904 DOI: 10.3747/co.24.3494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
75 Yoh T, Seo S, Taura K, Iguchi K, Ogiso S, Fukumitsu K, Ishii T, Kaido T, Uemoto S. Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival. Ann Surg. 2019;. [PMID: 31058698 DOI: 10.1097/sla.0000000000003358] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
76 Ding C, Cheng S, Yang Z, Lv Z, Xiao H, Du C, Peng C, Xie H, Zhou L, Wu J. Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells. Int J Mol Sci. 2014;15:4060-4076. [PMID: 24663081 DOI: 10.3390/ijms15034060] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 13.3] [Reference Citation Analysis]
77 Woo SM, Park JW, Han SS, Choi JI, Lee WJ, Park SJ, Hong EK, Kim CM. Isolated pancreatic metastasis of hepatocellular carcinoma after curative resection. World J Gastrointest Oncol 2010; 2(4): 209-212 [PMID: 21160600 DOI: 10.4251/wjgo.v2.i4.209] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
78 Xu L, Xue F, Wang B, Yan D, Ding W, Yin J, Yi C, Wang W. Hoarseness due to lymph node metastasis of hepatocellular carcinoma: A case report. Oncol Lett 2016;12:918-20. [PMID: 27446370 DOI: 10.3892/ol.2016.4687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
79 Shinya S, Noritomi T, Yamauchi Y, Sasaki T, Hamada Y, Yamashita Y. Two rare metachronous metastases of hepatocellular carcinoma after liver transplantation. Int Surg 2013;98:432-6. [PMID: 24229037 DOI: 10.9738/INTSURG-D-13-00026.1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
80 Wei T, Zhang XF, Xue F, Bagante F, Ratti F, Marques HP, Silva S, Soubrane O, Lam V, Poultsides GA, Popescu I, Grigorie R, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular Carcinoma. Ann Surg Oncol 2021. [PMID: 34019181 DOI: 10.1245/s10434-021-10142-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
81 Shimizu R, Tamai H, Mori Y, Shingaki N, Maeshima S, Nuta J, Maeda Y, Moribata K, Muraki Y, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M. The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma. Hepatol Int 2016;10:328-39. [DOI: 10.1007/s12072-015-9678-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
82 Nuta J, Tamai H, Mori Y, Shingaki N, Maeshima S, Shimizu R, Maeda Y, Moribata K, Niwa T, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma. Journal of Ultrasound in Medicine 2016;35:359-71. [DOI: 10.7863/ultra.15.04067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
83 Fu Y, Zhao H, Li X, Kang H, Ma J, Yao F, Du N. Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance. Tumor Biol 2014;35:11283-7. [DOI: 10.1007/s13277-014-2430-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
84 Midorikawa Y, Takayama T, Nakayama H, Moriguchi M, Aramaki O, Yamazaki S, Teramoto K, Yoshida N, Kobayashi N, Tsuji S, Higaki T. Favorable outcomes of surgical resection for extrahepatic recurrent hepatocellular carcinoma. Hepatol Res. 2020;50:978-984. [PMID: 32573905 DOI: 10.1111/hepr.13526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Kim R, Song J, Kim SB. Concurrent hepatocellular carcinoma metastasis to stomach, colon, and brain: A case report. World J Clin Cases 2020; 8(16): 3534-3541 [PMID: 32913860 DOI: 10.12998/wjcc.v8.i16.3534] [Reference Citation Analysis]
86 Schäfer T, Sperling J, Kollmar O, Richter S, Schilling MK, Menger MD, Lindemann W. Early effect of hepatic artery TNF-alpha infusion on systemic hemodynamics and inflammation: a dose-response study in pigs. Int J Colorectal Dis 2010;25:523-32. [PMID: 19888588 DOI: 10.1007/s00384-009-0827-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
87 Ding C, Cheng S, Yang Z, Lv Z, Xiao H, Du C, Peng C, Xie H, Zhou L, Wu J. Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells. Int J Mol Sci. 2014;15:4060-4076. [PMID: 24663081 DOI: 10.3390/ijms 15034060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Yeow GPV, Yeow DGE, Sankaran P, Maiyauen T, Sharif MS. Hemorrhagic extrahepatic recurrence of hepatocellular carcinoma: A case report. Ann Hepatobiliary Pancreat Surg 2019;23:77-9. [PMID: 30863813 DOI: 10.14701/ahbps.2019.23.1.77] [Reference Citation Analysis]
89 Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375-1382. [PMID: 18324443 DOI: 10.1245/s10434-008-9846-9] [Cited by in Crossref: 249] [Cited by in F6Publishing: 248] [Article Influence: 17.8] [Reference Citation Analysis]
90 Vossen JA, Buijs M, Syed L, Kutiyanwala F, Kutiyanwala M, Geschwind JH, Vali M. Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization. Clin Exp Metastasis 2008;25:811-7. [DOI: 10.1007/s10585-008-9195-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
91 Zhao Y, He K, Zheng H, Sun M, Shi T, Zheng X, Shao D, Zhang H, Guan F, Li J, Chen L. Berberine Inhibits the Apoptosis-Induced Metastasis by Suppressing the iPLA2/LOX-5/LTB4 Pathway in Hepatocellular Carcinoma. Onco Targets Ther 2020;13:5223-30. [PMID: 32606742 DOI: 10.2147/OTT.S243357] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Dai Y, Liu L, Zeng T, Zhu YH, Li J, Chen L, Li Y, Yuan YF, Ma S, Guan XY. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma. Biochem Biophys Res Commun 2013;436:711-8. [PMID: 23791740 DOI: 10.1016/j.bbrc.2013.06.021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
93 Wang J, Dong L, Xu L, Chu ES, Chen Y, Shen J, Li X, Wong CC, Sung JJ, Yu J. B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice. Cancer Letters 2014;355:192-200. [DOI: 10.1016/j.canlet.2014.08.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
94 Miyazaki K, Soyama A, Hidaka M, Hamasaki K, Yamanouchi K, Takatsuki M, Kanematsu T, Eguchi S. Ex vivo hepatic venography for hepatocellular carcinoma in livers explanted for liver transplantation. World J Surg Oncol 2011;9:111. [PMID: 21951398 DOI: 10.1186/1477-7819-9-111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
95 Hu J, Xu Y, Shen ZZ, Wang Z, Lu Q, Yang GH, Ding ZB, Fan J, Zhou J. High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. J Cancer Res Clin Oncol. 2009;135:1359-1367. [PMID: 19350273 DOI: 10.1007/s00432-009-0577-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
96 Nakamura M, Nagano H, Marubashi S, Miyamoto A, Takeda Y, Kobayashi S, Wada H, Noda T, Dono K, Umeshita K, Monden M. Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis. Cancer 2008;112:1765-71. [PMID: 18327806 DOI: 10.1002/cncr.23356] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
97 Tanaka K, Shimada H, Matsuo K, Takeda K, Nagano Y, Togo S. Clinical features of hepatocellular carcinoma developing extrahepatic recurrences after curative resection. World J Surg. 2008;32:1738-1747. [PMID: 18463920 DOI: 10.1007/s00268-008-9613-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
98 Sumie S, Nakashima O, Okuda K, Kuromatsu R, Kawaguchi A, Nakano M, Satani M, Yamada S, Okamura S, Hori M, Kakuma T, Torimura T, Sata M. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma. Ann Surg Oncol 2014;21:1002-9. [PMID: 24254204 DOI: 10.1245/s10434-013-3376-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 8.4] [Reference Citation Analysis]
99 Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Tajiri N, Satani M, Niizeki T, Aino H, Okamura S, Iwamoto H. Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study. Cancer Med. 2015;4:1836-1843. [PMID: 26471348 DOI: 10.1002/cam4.548] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
100 Lee SH, Lee JS, Na GH, You YK, Kim DG. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation. Clin Transplant. 2017;31. [PMID: 27653235 DOI: 10.1111/ctr.12852] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
101 Ochi H, Hirooka M, Hiraoka A, Koizumi Y, Abe M, Sogabe I, Ishimaru Y, Furuya K, Miyagawa M, Kawasaki H, Michitaka K, Takada Y, Mochizuki T, Hiasa Y. 18F-FDG-PET/CT predicts the distribution of microsatellite lesions in hepatocellular carcinoma. Mol Clin Oncol. 2014;2:798-804. [PMID: 25054048 DOI: 10.3892/mco.2014.328] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
102 Huang H, Zhang XF, Zhou HJ, Xue YH, Dong QZ, Ye QH, Qin LX. Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection. Cancer Sci. 2010;101:1314-1319. [PMID: 20345480 DOI: 10.1111/j.1349-7006.2010.01524.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
103 Tomimaru Y, Wada H, Eguchi H, Tomokuni A, Hama N, Kawamoto K, Marubashi S, Umeshita K, Doki Y, Mori M, Wakasa K, Nagano H. Clinical significance of surgical resection of metastatic lymph nodes from hepatocellular carcinoma. Surg Today. 2015;45:1112-1120. [PMID: 25205550 DOI: 10.1007/s00595-014-1028-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
104 Liu Y, Wu C, Wang Y, Wen S, Wang J, Chen Z, He Q, Feng D. Loss of plexin-B3 in hepatocellular carcinoma. Exp Ther Med 2015;9:1247-52. [PMID: 25780417 DOI: 10.3892/etm.2015.2243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
105 Morita K, Shirabe K, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Ikegami T, Yamashita Y, Sugimachi K, Harimoto N, Itoh S, Ikeda T, Maehara Y. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation: MIR-18A and MIR-199A-5P in HCC Recurrence. Liver Transpl 2016;22:665-76. [DOI: 10.1002/lt.24400] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
106 Cai MY, Luo RZ, Chen JW, Pei XQ, Lu JB, Hou JH, Yun JP. Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma. PLoS One 2012;7:e32838. [PMID: 22393452 DOI: 10.1371/journal.pone.0032838] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
107 Tomimaru Y, Eguchi H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Umeshita K, Kim T, Wakasa K, Doki Y, Mori M, Nagano H. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma. Int J Cancer 2012;130:319-27. [PMID: 21328580 DOI: 10.1002/ijc.25994] [Cited by in F6Publishing: 32] [Reference Citation Analysis]
108 Yoh T, Seo S, Ogiso S, Kawai T, Okuda Y, Ishii T, Taura K, Higashi T, Nakamoto Y, Hatano E, Kaido T, Uemoto S. Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating 18F-FDG-PET Imaging with the ALBI Grade. Ann Surg Oncol. 2018;25:542-549. [PMID: 29168098 DOI: 10.1245/s10434-017-6262-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
109 Ng KM, Niu R, Yan TD, Zhao J, McKay E, Chu FC, Morris DL. Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma. HPB (Oxford) 2008;10:388-95. [PMID: 19088923 DOI: 10.1080/13651820802074449] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
110 Fu Y, Feng MX, Yu J, Ma MZ, Liu XJ, Li J, Yang XM, Wang YH, Zhang YL, Ao JP, Xue F, Qin W, Gu J, Xia Q, Zhang ZG. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling. Oncotarget 2014;5:6701-15. [PMID: 25149533 DOI: 10.18632/oncotarget.2239] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
111 Malouf GG, Brugières L, Le Deley MC, Faivre S, Fabre M, Paradis V, Aerts I, Le Tourneau C, Dreyer C, Branchereau S, Belghiti J, Raymond E. Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection. Cancer 2012;118:4981-90. [PMID: 22415897 DOI: 10.1002/cncr.27520] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
112 Hai S, Okada T, Iimuro Y, Hirano T, Suzumura K, Fujimoto J. Successful laparoscopic extirpation of peritoneal dissemination after hepatectomy for ruptured hepatocellular carcinoma. Asian J Endosc Surg 2015;8:465-7. [PMID: 26708587 DOI: 10.1111/ases.12212] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
113 Huang D, Du X, Yuan R, Chen L, Liu T, Wen C, Huang M, Li M, Hao L, Shao J. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation. Biochemical and Biophysical Research Communications 2014;453:49-56. [DOI: 10.1016/j.bbrc.2014.09.061] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
114 Fang Y, Fu D, Tang W, Cai Y, Ma D, Wang H, Xue R, Liu T, Huang X, Dong L, Wu H, Shen X. Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013;1833:559-72. [DOI: 10.1016/j.bbamcr.2012.11.020] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
115 Tao YM, Liu Z, Liu HL. Dickkopf-1 (DKK1) promotes invasion and metastasis of hepatocellular carcinoma. Dig Liver Dis. 2013;45:251-257. [PMID: 23266194 DOI: 10.1016/j.dld.2012.10.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
116 Aino H, Sumie S, Niizeki T, Kuromatsu R, Tajiri N, Nakano M, Satani M, Yamada S, Okamura S, Shimose S. Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. Mol Clin Oncol. 2014;2:393-398. [PMID: 24772306 DOI: 10.3892/mco.2014.259] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
117 Portolani N, Baiocchi GL, Gheza F, Molfino S, Lomiento D, Giulini SM. Parietal and peritoneal localizations of hepatocellular carcinoma: is there a place for a curative surgery? World J Surg Oncol 2014;12:298. [PMID: 25255984 DOI: 10.1186/1477-7819-12-298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
118 Zhang K, Jiang L, He R, Li BL, Jia Z, Huang RH, Mu Y. Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma. Tumour Biol 2014;35:7669-73. [PMID: 24801906 DOI: 10.1007/s13277-014-2023-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
119 Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM, Zheng SS. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29:1810-1816. [PMID: 21678027 DOI: 10.1007/s12032-011-0004- z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Lu WP, Dong JH. Hepatectomy for hepatocellular carcinoma in the era of liver transplantation. World J Gastroenterol 2014; 20(28): 9237-9244 [PMID: 25071316 DOI: 10.3748/wjg.v20.i28.9237] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
121 Wang J, Li J, Shen J, Wang C, Yang L, Zhang X. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer. 2012;12:227. [PMID: 22681717 DOI: 10.1186/1471-2407-12-227] [Cited by in Crossref: 109] [Cited by in F6Publishing: 113] [Article Influence: 10.9] [Reference Citation Analysis]
122 Miyauchi W, Yamamoto M, Masahiro M, Shishido Y, Miyatani K, Matsunaga T, Sakamoto T, Fujiwara Y. Colonic metastasis of hepatocellular carcinoma with repeated retroperitoneal bleeding: a case report. Surg Case Rep 2021;7:261. [PMID: 34921642 DOI: 10.1186/s40792-021-01349-7] [Reference Citation Analysis]
123 Ishii T, Hatano E, Yasuchika K, Taura K, Seo S, Uemoto S. High risk of lung metastasis after resection of hepatocellular carcinoma more than 7 cm in diameter. Surg Today 2014;44:1900-5. [PMID: 24264061 DOI: 10.1007/s00595-013-0792-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
124 Wu J, Zhu P, Zhang Z, Zhang B, Shu C, Mba'nbo-koumpa A, Zhang Z, Huang Z, Zhang W, Lau WY, Chen X. Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy. European Journal of Surgical Oncology 2019;45:1887-94. [DOI: 10.1016/j.ejso.2019.02.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
125 Ng W, Jacob S, Delaney G, Do V, Barton M. Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: setting an evidence-based benchmark for the best-quality cancer care. Gastroenterol Res Pract 2015;2015:753480. [PMID: 25883645 DOI: 10.1155/2015/753480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
126 Zhou ZJ, Luo CB, Xin HY, Hu ZQ, Zhu GQ, Li J, Zhou SL. MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling. NPJ Genom Med 2020;5:15. [PMID: 32257385 DOI: 10.1038/s41525-020-0122-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
127 Morio K, Kawaoka T, Aikata H, Namba M, Uchikawa S, Kodama K, Ohya K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Tsuge M, Hiramatsu A, Imamura M, Nakamura Y, Akagi M, Awai K, Kobayashi T, Ohdan H, Chayama K. Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection. Eur J Radiol. 2020;124:108828. [PMID: 31955034 DOI: 10.1016/j.ejrad.2020.108828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
128 Kishi Y, Hasegawa K, Sugawara Y, Kokudo N. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol. 2011;2011:728103. [PMID: 21994868 DOI: 10.4061/2011/728103] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
129 Li PD, Chen P, Peng X, Ma C, Zhang WJ, Dai XF. HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition. Aging (Albany NY) 2018;10:115-30. [PMID: 29348394 DOI: 10.18632/aging.101363] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
130 Kashima M, Yamakado K, Takaki H, Kaminou T, Tanigawa N, Nakatsuka A, Takeda K. Radiofrequency ablation for the treatment of bone metastases from hepatocellular carcinoma. AJR Am J Roentgenol. 2010;194:536-541. [PMID: 20093621 DOI: 10.2214/ajr.09.2975] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
131 Imaoka Y, Ohira M, Yano T, Nakano R, Tanimine N, Shimizu S, Kuroda S, Tahara H, Kobayashi T, Ohdan H. Polymorphisms in TRAIL predict long-term survival and extrahepatic recurrence following initial hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2018;25:370-6. [PMID: 30051596 DOI: 10.1002/jhbp.573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
132 Yang Z, Sun B, Li Y, Zhao X, Zhao X, Gu Q, An J, Dong X, Liu F, Wang Y. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma. Experimental and Molecular Pathology 2015;98:352-9. [DOI: 10.1016/j.yexmp.2015.03.030] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
133 Ma J, Zhang L, Yang P, Zeng ZC, Xiang ZL. Integrated analysis of long noncoding RNA expression profiles in lymph node metastasis of hepatocellular carcinoma. Gene. 2018;676:47-55. [PMID: 29981417 DOI: 10.1016/j.gene.2018.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
134 Akita H, Marubashi S, Wada H, Hama N, Kawamoto K, Kobayashi S, Eguchi H, Doki Y, Mori M, Nagano H. Combination therapy with S-1 and interferon-α in hepatocellular carcinoma patients with lung metastasis. Mol Clin Oncol 2015;3:322-8. [PMID: 25798261 DOI: 10.3892/mco.2014.463] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
135 Kishi Y, Saiura A, Yamamoto J, Koga R, Seki M, Morimura R, Yoshioka R, Kokudo N, Yamaguchi T. Repeat treatment for recurrent hepatocellular carcinoma: is it validated? Langenbecks Arch Surg. 2011;396:1093-1100. [PMID: 21847622 DOI: 10.1007/s00423-011-0837-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
136 Shuyao W, Mingyang B, Feifei M, Xiaoqin H. CK19 Predicts Recurrence and Prognosis of HBV Positive HCC. J Gastrointest Surg 2021. [PMID: 34506016 DOI: 10.1007/s11605-021-05107-w] [Reference Citation Analysis]
137 Al-Sharydah AM, Al-Abdulwahhab AH, Alghnimi IA, El Shawarby MA, Katbi FA. Mastalgia as an atypical presentation of hepatocellular carcinoma: a case report. World J Surg Oncol 2017;15:58. [PMID: 28279206 DOI: 10.1186/s12957-017-1133-4] [Reference Citation Analysis]
138 Ho MC, Hasegawa K, Chen XP, Nagano H, Lee YJ, Chau GY, Zhou J, Wang CC, Choi YR, Poon RT, Kokudo N. Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). Liver Cancer 2016;5:245-56. [PMID: 27781197 DOI: 10.1159/000449336] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
139 Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, Goto T, Omata M, Yoshida H, Koike K. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer. 2011;117:4475-4483. [PMID: 21437884 DOI: 10.1002/cncr.25960] [Cited by in Crossref: 228] [Cited by in F6Publishing: 209] [Article Influence: 20.7] [Reference Citation Analysis]
140 Feng J, He Y, Wan J, Chen Z. Pulmonary metastases in newly diagnosed hepatocellular carcinoma: a population-based retrospective study. HPB (Oxford) 2020;22:1295-304. [PMID: 31892468 DOI: 10.1016/j.hpb.2019.12.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Poon RT, Borys N. Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 2009;10:333-43. [PMID: 19236203 DOI: 10.1517/14656560802677874] [Cited by in Crossref: 131] [Cited by in F6Publishing: 127] [Article Influence: 10.1] [Reference Citation Analysis]
142 Kato R, Sakamoto A, Noguchi T, Matsuda S, Terajima H. Solitary Metastasis of Hepatocellular Carcinoma to the Rectus Abdominis 13 Years After the Initial Treatment. ACG Case Rep J 2021;8:e00607. [PMID: 34036115 DOI: 10.14309/crj.0000000000000607] [Reference Citation Analysis]
143 Rahim EA, Noh MS, Ngah NA, Suraini MS, Yusof MM. Hepatocellular carcinoma with disseminated skeletal muscle metastasis. Acta Radiol Open 2017;6:2058460117716705. [PMID: 28811928 DOI: 10.1177/2058460117716705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]